Diabetic nephropathy: current diagnostics and treatment

Der Internist
S WerthJ Steinhoff

Abstract

Diabetic kidney disease is a leading cause of renal failure in Germany. Albuminuria is an early diagnostic indicator of renal damage in diabetes and, aside from renal failure, a major risk factor of cardiovascular disease. An early diagnosis of diabetic kidney disease is of great importance to reduce associated cardiovascular mortality; glycemic control should aim for HbA1c levels of < 7 %. Guidelines on blood pressure differ, but it should generally be reduced to < 140/90 mmHg; stricter limits should be applied if albuminuria is present. ACE inhibitors (ACE-I) or angiotensin receptor blockers (ARB) should be preferred for blood pressure control. A combination of ACE-Is and ARBs or a renin-inhibitor therapy does not improve cardiovascular outcome, instead it increases the rate of adverse events, e.g., hyperkalemia or renal failure. Lipid control, usually with statins, should be started at an early phase of renal failure. Vitamin D receptor activation and uric acid reduction might play a future role in the treatment of diabetic kidney disease. Pharmacological modification of inflammatory signaling appears to be promising but is not yet of clinical relevance.

References

Jun 6, 2003·The New England Journal of Medicine·Bruce A PerkinsAndrzej S Krolewski
Nov 13, 2004·JAMA : the Journal of the American Medical Association·George L BakrisUNKNOWN GEMINI Investigators
Jan 16, 2009·Journal of the American Society of Nephrology : JASN·René R WenzelUNKNOWN SPP301 (Avosentan) Endothelin Antagonist Evaluation in Diabetic Nephropathy Study Investigators
Jul 3, 2009·The New England Journal of Medicine·Michael MauerRonald Klein
Nov 17, 2009·Diabetes Research and Clinical Practice·R K SimmonsS J Griffin
Mar 17, 2010·The New England Journal of Medicine·William C CushmanFaramarz Ismail-Beigi
Mar 1, 2011·Journal of the American Society of Nephrology : JASN·Elizabeth T RosolowskyAndrzej S Krolewski
Jun 11, 2011·Contributions to Nephrology·Christine Maric, John E Hall
Jun 28, 2011·The New England Journal of Medicine·Pablo E PergolaUNKNOWN BEAM Study Investigators
Jan 24, 2012·Journal of the American Society of Nephrology : JASN·Monika A NiewczasAndrzej S Krolewski
Jan 24, 2012·Journal of the American Society of Nephrology : JASN·Tomohito GohdaAndrzej S Krolewski
Nov 7, 2012·Journal of the American Heart Association·Ebrahim BarkoudahMarc A Pfeffer
Oct 17, 2013·Clinical and Experimental Nephrology·Antien L Mooyaart
Nov 12, 2013·The New England Journal of Medicine·Linda F FriedUNKNOWN VA NEPHRON-D Investigators
Nov 12, 2013·The New England Journal of Medicine·Dick de ZeeuwUNKNOWN BEACON Trial Investigators
Feb 21, 2014·The American Journal of the Medical Sciences·Aidar R GosmanovElvira O Gosmanova
Apr 3, 2014·Deutsche medizinische Wochenschrift·T HellerU A Müller
Oct 10, 2014·Acta Diabetologica·Giuseppe Pugliese
Oct 25, 2014·International Journal of Nephrology and Renovascular Disease·Andy Kh Lim
Nov 20, 2014·The New England Journal of Medicine·Marcus LindAnnika Rosengren
Dec 17, 2014·World Journal of Diabetes·Yi-Jing Sheen, Wayne Hh Sheu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disorder in Diabetes

Diabetes is associated with an increased risk of cardiovascular disorders and heart failure. Discover the latest research here.

Related Papers

Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
Nasreen A Al-SayedRobert S Zimmerman
Kidney International
Lennart TonneijckDaniël H van Raalte
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
Hiromichi SuzukiRyuichiro Araki
© 2021 Meta ULC. All rights reserved